NCT04544553

Brief Summary

Brief Summary: Diabetic retinopathy (DR) is a leading cause of visual impairment and has major public health implications globally and especially in countries such as India where the prevalence of diabetes is high. With timely screening and intervention, the disease progression to blindness can be prevented but several barriers exist to the provision of care. The long term aim is to identify the barriers to DR screening and to plan potential interventional strategies. From the qualitative study, the reasons such as lack of awareness or knowledge, distance to travel, lack of reminder system were identified as a reason for poor follow-up. This lead to the development of interventional strategies. This was a randomized, investigator-masked clinical trial that was conducted in a tertiary eye care centre in South India. Consecutive patients with diabetes who were residents in Chennai and its vicinity of approximately 100 km radius and who were undergoing repeated intravitreal injections for DME were recruited into the trial. The aim of the study is to investigate the effect of SMS informational reminders among patients with Diabetic macular edema for the follow-up. They study consists of 2 groups, SMS reminder group receives the reminders 1 week and 2 days prior to the scheduled appointments with the concerned doctor on a particular date and time, whereas other group does not receive any reminders for the appointment schedule. After the follow-up, the patients will be screened for the attendance at the review visit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 24, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 14, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 3, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 10, 2020

Completed
Last Updated

September 14, 2020

Status Verified

September 1, 2020

Enrollment Period

7 months

First QC Date

September 3, 2020

Last Update Submit

September 10, 2020

Conditions

Keywords

screeningfollow-upshort message service

Outcome Measures

Primary Outcomes (1)

  • Attendance rates in patients with diabetic macular edema receiving short messaging services

    To investigate the effect of SMS informational reminders on adherence with scheduled eye examinations among patients with center involving DME receiving intravitreal injections in a tertiary eye care institute in South India.

    7 months

Study Arms (2)

SMS reminder

OTHER

This arm receive SMS reminder for the follow-up of DR Screening

Other: SMS reminder

No SMS reminder

OTHER

This arm did not receive SMS reminder for the follow-up of DR Screening

Other: No SMS reminder

Interventions

The group receives reminder for the follow-up at 1 week and 2 days prior to their scheduled appointments.

SMS reminder

The group did not receives any SMS regarding scheduled appoinments.

No SMS reminder

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with \> 40 years of age
  • Diagnosed as centre involving Diabetic macular edema (DME)
  • Patients who received intravitreal injections for DME
  • Ability to give informed consent

You may not qualify if:

  • Patients from outside the area of residence who stayed more than 100 km from the hospital
  • Patients with ocular co-morbidities other than DME

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rajiv Raman

Chennai, Tamil Nadu, 600006, India

Location

Related Publications (1)

  • Kumar G, Velu S, Prakash VJ, Kumar S, Sivaprasad S, Sharma A, Raman R. Attendance Rate in Patients with Diabetic Macular Edema Receiving Short Messages. Ophthalmol Retina. 2021 Oct;5(10):1054-1056. doi: 10.1016/j.oret.2021.03.005. Epub 2021 Mar 7. No abstract available.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant (Ophthalmologist)

Study Record Dates

First Submitted

September 3, 2020

First Posted

September 10, 2020

Study Start

January 24, 2019

Primary Completion

August 14, 2019

Study Completion

August 14, 2019

Last Updated

September 14, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

The datasets generated during and/or analysed during the study are not publicly available, as it against the organization hospital policy. But are available from the corresponding author on reasonable request.

Locations